The following is a reconciliation of the basic and diluted loss per share computations for the three and six months ended June 30, 2026, and 2025:


	Three Months Ended June 30,						Six Months Ended June 30,
	2026			2025			2026			2025
	(in thousands)
Net loss attributable to Fulgent	$	(29,530	)	$	(18,957	)	$	(54,356	)	$	(30,487	)

Weighted-average common shares - outstanding, basic		28,005			30,544			29,435			30,687
Weighted-average common shares - outstanding, diluted		28,005			30,544			29,435			30,687

Loss per share:
Basic	$	(1.05	)	$	(0.62	)	$	(1.85	)	$	(0.99	)
Diluted	$	(1.05	)	$	(0.62	)	$	(1.85	)	$	(0.99	)

The following securities have been excluded from the calculation of diluted loss per share because their effect would have been anti-dilutive:


	Three Months Ended June 30,				Six Months Ended June 30,
	2026		2025		2026		2025
	(in thousands)
Stock options		75		101		75		101
Restricted stock units		2,458		2,187		2,458		2,187
Contingently issuable shares		293		—		293		—

The anti-dilutive shares described above were calculated using the treasury stock method. In the three and six months ended June 30, 2026, and 2025, the Company had outstanding stock options and restricted stock units that were excluded from the weighted-average share calculation for continuing operations due to the Company’s net loss positions.

In the three and six months ended June 30, 2026, the Company also had contingently issuable shares for contingent consideration to the acquisition of ANP that were excluded from the weighted-average share calculation for continuing operations due to the Company’s net loss positions. The milestones have not been satisfied as of June 30, 2026, thus, nothing was included in dilutive shares.